KASTEN BERNARD L 4
4 · CLEVELAND BIOLABS INC · Filed Oct 29, 2012
Insider Transaction Report
Form 4
KASTEN BERNARD L
Director
Transactions
- Award
Stock Options (Right to Buy)
2012-10-25+100,000→ 100,000 totalExercise: $1.45→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]100% of the stock options shall vest on December 31, 2012 if certain goals are achieved prior to such time. If such goals are not satisfied as of December 31, 2012, the options will not vest and will expire on December 31, 2012. If such goals are satisfied as of December 31, 2012, the options will vest and will expire on August 13, 2022.